100 related articles for article (PubMed ID: 6775808)
1. Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function.
Manni A; Pearson OH
Cancer Treat Rep; 1980; 64(6-7):779-85. PubMed ID: 6775808
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
3. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
[TBL] [Abstract][Full Text] [Related]
4. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
Ravdin PM; Fritz NF; Tormey DC; Jordan VC
Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
[TBL] [Abstract][Full Text] [Related]
5. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
Sawka CA; Pritchard KI; Paterson AH; Sutherland DJ; Thomson DB; Shelley WE; Myers RE; Mobbs BG; Malkin A; Meakin JW
Cancer Res; 1986 Jun; 46(6):3152-6. PubMed ID: 3084082
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
7. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Rose DP; Davis TE
Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
[TBL] [Abstract][Full Text] [Related]
8. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
Yasumura T; Oka T; Honjo H; Okada H
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
[TBL] [Abstract][Full Text] [Related]
9. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH
Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666
[TBL] [Abstract][Full Text] [Related]
10. Effects of postoperative adjuvant chemotherapy and radiotherapy on ovarian function in women undergoing treatment for soft tissue sarcoma.
Shamberger RC; Sherins RJ; Ziegler JL; Glatstein E; Rosenberg SA
J Natl Cancer Inst; 1981 Dec; 67(6):1213-8. PubMed ID: 6796744
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the serum level of female sex hormones following radiocastration using different total doses].
Naujokat B; Rohloff R; Willich N; Eiermann W
Strahlenther Onkol; 1988 Apr; 164(4):208-13. PubMed ID: 3129800
[TBL] [Abstract][Full Text] [Related]
12. [Effect of chemotherapy to ovary function in ovarian malignancy patients undergoing conservative surgery].
Sun ZY; Shen K; Lang JH; Huang HF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):431-3. PubMed ID: 12974089
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
14. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma.
Shamberger RC; Rosenberg SA; Seipp CA; Sherins RJ
Cancer Treat Rep; 1981; 65(9-10):739-46. PubMed ID: 6791818
[TBL] [Abstract][Full Text] [Related]
15. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
[TBL] [Abstract][Full Text] [Related]
16. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum estrogen levels in women during tamoxifen therapy.
Lum SS; Woltering EA; Fletcher WS; Pommier RF
Am J Surg; 1997 May; 173(5):399-402. PubMed ID: 9168075
[TBL] [Abstract][Full Text] [Related]
18. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
19. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cyst formation in patients using tamoxifen for breast cancer.
Metindir J; Aslan S; Bilir G
Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
